1. Home
  2. HUMA vs UIS Comparison

HUMA vs UIS Comparison

Compare HUMA & UIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • UIS
  • Stock Information
  • Founded
  • HUMA 2004
  • UIS 1942
  • Country
  • HUMA United States
  • UIS United States
  • Employees
  • HUMA N/A
  • UIS N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • UIS EDP Services
  • Sector
  • HUMA Health Care
  • UIS Technology
  • Exchange
  • HUMA Nasdaq
  • UIS Nasdaq
  • Market Cap
  • HUMA 250.2M
  • UIS 271.5M
  • IPO Year
  • HUMA N/A
  • UIS N/A
  • Fundamental
  • Price
  • HUMA $1.51
  • UIS $3.91
  • Analyst Decision
  • HUMA Strong Buy
  • UIS Buy
  • Analyst Count
  • HUMA 8
  • UIS 2
  • Target Price
  • HUMA $10.88
  • UIS $7.75
  • AVG Volume (30 Days)
  • HUMA 5.9M
  • UIS 874.6K
  • Earning Date
  • HUMA 08-11-2025
  • UIS 10-28-2025
  • Dividend Yield
  • HUMA N/A
  • UIS N/A
  • EPS Growth
  • HUMA N/A
  • UIS N/A
  • EPS
  • HUMA N/A
  • UIS N/A
  • Revenue
  • HUMA $818,000.00
  • UIS $1,957,800,000.00
  • Revenue This Year
  • HUMA N/A
  • UIS N/A
  • Revenue Next Year
  • HUMA $949.92
  • UIS $3.79
  • P/E Ratio
  • HUMA N/A
  • UIS N/A
  • Revenue Growth
  • HUMA N/A
  • UIS N/A
  • 52 Week Low
  • HUMA $1.15
  • UIS $3.56
  • 52 Week High
  • HUMA $6.77
  • UIS $8.93
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 36.87
  • UIS 45.36
  • Support Level
  • HUMA $1.43
  • UIS $3.90
  • Resistance Level
  • HUMA $1.67
  • UIS $4.20
  • Average True Range (ATR)
  • HUMA 0.15
  • UIS 0.14
  • MACD
  • HUMA -0.01
  • UIS 0.02
  • Stochastic Oscillator
  • HUMA 23.32
  • UIS 48.25

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. Majority of revenue is from ECS segment.

Share on Social Networks: